The largest database of trusted experimental protocols

8 protocols using wallac microbeta counter

1

Inhibition of Th1 Responder Clone Proliferation by HLA-E Restricted T-cell Clones

Check if the same lab product or an alternative is used in the 5 most similar protocols
HLA-E restricted peptide specific T-cell clones were tested for their ability to inhibit proliferation of a Th1 responder clone (Rp15 1-1) as previously described [23 (link),58 (link)–60 (link)]. Rp15 1-1 T-cells (1x10e4 c/w) were cultured in a 96-well flat-bottom plate with irradiated (20 Gy), HLA-DR3 matched PBMCs as antigen presenting cells (5x10e4 c/w) and 0.05–0.1 μg/ml of hsp65 peptide 3–13, specific for the Th1 responder clone, in the absence or presence of HLA-E restricted T-cell clones (0.6–5x10e4 c/w). Proliferation was measured by [3H] TdR incorporation (0.5 μCi/well, Perkin Elmer, Groningen, the Netherlands) after 96 hours. Cells were harvested with a 96-well Tomtec cell harvester (Synchron, Etten-Leur, the Netherlands) and counts per minute (cpm) were determined using a Wallac MicroBeta counter (Perkin Elmer, Groningen, The Netherlands).
+ Open protocol
+ Expand
2

Quantifying Insulin-Stimulated Cell Proliferation

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA synthesis was carried out as described in Gaugin et al.46 (link). Briefly, L6 rat skeletal myoblasts overexpressing human IR-A, were plated in a 96-well flat bottom plate (1.5 × 104 cells/well) and grown overnight at 37 °C, 5% CO2. Cells were starved in serum-free medium for 4 h before treatment with increasing ligand concentrations for 18 h in Dulbecco’s minimal essential medium with 1% bovine serum albumin. The cells were incubated with 0.13 μCi/well [3H]-thymidine for 4 h, shaken for 2 h with 50 μL disrupting buffer (40 mM Tris pH 7.5/10 mM EDTA/150 mM NaCl) and then harvested onto glass fibre filters (Millipore®) using a MICRO 96TM Skatron harvester (Molecular Devices). The filters were counted in a Wallac MicroBeta counter (PerkinElmer Life Sciences). Assays were performed in triplicate in at least three independent experiments.
+ Open protocol
+ Expand
3

Hypoxia Effects on CD4+ T Cell Proliferation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Isolated CD4+ T cells were stimulated and cultured in DMEM 1X (no glucose, no glutamine) with 5% NaHCO3, 10% dialyzed FBS, 14 mM D-glucose and indicated amounts of L-Glutamine. Ten thousand cells were incubated in 100 μl of media under hypoxia (O2 = 1%) or normoxia (O2 = 20%) for 72 hours during which H3-thymidine (1μCi/well; PerkinElmer,Boston,MA,USA) was added to the media for the last 12 hours of incubation. H3-thymidine incorporation on the 72nd hour was obtained using a Wallac MicroBeta Counter (Perkin Elmer).
+ Open protocol
+ Expand
4

T-cell Proliferation Assay with OVA

Check if the same lab product or an alternative is used in the 5 most similar protocols
T-cell proliferation assays were performed as previously described.28 (link) In short, DC were pulsed with indicated concentrations of OVA-LeB, OVA-aDC-SIGN, OVA-isotype ctrl or native OVA for 4 h before incubation with OVA-specific T-cells (OT-I or OT-II; 1:2 DC:T). [3H]-thymidine (1μCi/well; Amersham Biosciences, NJ, USA) was present during the last 16 h of a 72 h culture. [3H]-thymidine incorporation was measured using a Wallac microbeta counter (Perkin-Elmer, USA).
+ Open protocol
+ Expand
5

Cell Proliferation Assay for Insulin Receptor-A

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA synthesis was carried out as described in Ref. (7 (link)). The rate of proliferation of R IR-A cells was such that a sufficient difference between stimulated and unstimulated cells was not easily achieved. Therefore, the well-characterized L6 rat skeletal myoblasts stably overexpressing human IR-A were used. Briefly, L6 rat skeletal myoblasts (1.5 × 104 cells/well), stably overexpressing human IR-A, were plated in a 96-well flat-bottom plate and grown overnight at 37°C, 5% CO2. Cells were starved in SFM for 4 h before treatment with insulin, IGF-II, qIGF-I, or S597 with increasing ligand concentrations for 19 h in Dulbecco’s minimal essential medium with 1% bovine serum albumin. The cells were pulsed with 0.14 μCi/well [3H] thymidine for 4 h and harvested onto glass fiber filters (Millipore®) using a MICRO 96™ Skatron harvester (Molecular Devices). The filters were counted in a Wallac MicroBeta counter (PerkinElmer Life Sciences).
+ Open protocol
+ Expand
6

Binding Assay for H1 Receptor Ligands

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dulbecco’s Modified
Eagle’s
Medium was acquired from Sigma Aldrich (St. Louis, MO, USA). Medium
was supplemented with fetal bovine serum and penicillin/streptomycin
from GE healthcare (Uppsala, Sweden). Linear polyethylenimine (25
kDa) was acquired from Polysciences (Warrington, PA, USA). HBSS, trypsin,
and the BCA protein assay were bought from Thermo Fischer Scientific
(Waltham, MA, USA). The Branson sonifier 250 homogenizer was bought
from Emerson (St. Louis, MO, USA). GF/C plates, Microscint-O, [3H]mepyramine,
the cell harvester, and the Wallac Microbeta counter were all bought
from Perkin Elmer (Waltham, MA, USA). Diphenhydramine hydrochloride
was purchased from Sigma Aldrich. Mepyramine maleate was obtained
from Research Biochemicals International. Triprolidine hydrochloride
was purchased from Tocris. Azatadine dimaleate and desloratadine were
purchased from HaiHang Industry Co., Ltd. Cyclizine hydrochloride
was purchased from Toronto Research Chemicals (TRC). Stock solutions
of H1R binding compounds were made at 10 mM in DMSO and
were further diluted to a final concentration of ≤1% DMSO in
binding experiments.
+ Open protocol
+ Expand
7

Dendritic Cell-T Cell Interactions

Check if the same lab product or an alternative is used in the 5 most similar protocols
BM-DC were cultured as previously described (Singh et al., 2009a (link)). BM of Myd88/Ticam1 DKO (referred to as MyD88/TRIF DKO) and Ctss-/-(referred to as Cat-S KO) mice was kindly provided by Dr. T. Sparwasser (Twincore, Hannover, Germany) and Dr. K. Rock (Massachusetts Medical School, Worcester, MA, USA), respectively. CD11c+ spDCs were isolated as previously described (Singh et al., 2009a (link)). OVA-specific CD4+ and CD8+ T cells were isolated from spleen and lymph nodes cell suspensions from OT-II and OT-I mice, respectively, using the mouse CD4 and CD8 negative isolation kit (Invitrogen, CA, USA) according to manufacturer’s protocol. T cell proliferation assays were performed as described (Singh et al., 2009a (link)). In short,DCs were pulsed with OVA-LeX or OVA for 4h before incubation with OVA-specific OT-I or OT-II T cells (2:1 DC:T). [3H]-Thymidine (1 µCi/well; Amersham Biosciences) was present during the last 16h of a 72h culture. [3H]-Thymidine incorporation was measured using a Wallac microbeta counter (Perkin-Elmer). Alternatively, OT-I or OT-II T cells were labeled with CFSE and after 3 days dilution of CFSE was analyzed by flow cytometry. Differentiation of naive OT-II T cells, induced by OVA-LeX or OVA -pulsed BM-DCs or spDCs, was measured by an in vitro Th differentiation assay described earlier (Singh et al., 2011 (link)).
+ Open protocol
+ Expand
8

Hypoxia Modulates T Cell Proliferation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Isolated CD4+ T cells were stimulated and cultured in DMEM 1× (no glucose, no glutamine) with 5% NaHCO3, 10% dialyzed FBS, 14 mM d-glucose or RPMI 1640 (Sigma–Aldrich) supplemented with 10% heat inactivated FBS (Sigma–Aldrich); 2 mM glutamine (Sigma–Aldrich) 0.5% Penicillin-Streptomycin (Sigma–Aldrich). 5 × 106 T cells were incubated in 150 μl of media under hypoxia (O2 = 1%) or normoxia (O2 = 21%) for 72 h during which H3-thymidine (1 μCi/well; PerkinElmer, Boston, MA, U.S.A.) was added to the media for the last 12 h of incubation. H3-thymidine incorporation on the 72nd hour was counted using a Wallac MicroBeta Counter (PerkinElmer).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!